Viatris Inc — Form 8-K
Filed October 8, 2026 · analyzed by the 8-K Agent
8-K
▲ Likely positive
significance 72/100
What the filing says
Viatris Inc. (via wholly owned subsidiary Peach Purchaser Sub Inc.) agreed on October 8, 2026 to acquire Pacira BioSciences, Inc. through a two-step transaction: a cash tender offer at $36.50 per share followed by a merger. As of October 7, 2026, Pacira had 39,912,226 shares outstanding (excluding 9,018,591 treasury shares). The offer price of $36.50 per share represents the sole consideration; equity awards (options, RSUs, PSUs) convert to cash at the offer price, and the company's $287.5M convertible notes are addressed separately. Viatris committed sufficient funds without financing contingency; the transaction is expected to close shortly after tender offer acceptance.
Why this rating
Material acquisition (~$1.46B equity value) representing ~14% of Viatris's $10.4B market cap. Significant for target but requires regulatory approval, which is manageable. Transformational for Pacira but not disruptive-level for acquirer.
Tradability signal
NO TRADE
No trade: positive news with only -1.2% moved so far — good news prices in within seconds and long-side continuation has shown no measured edge (this cell: -0.60% over 4 hrs, n=174). (Filing arrived outside market hours — evaluated at the next open with a live quote.)
Derived from this site's own measured outcomes + live price/liquidity at analysis time. An experiment, not investment advice.
Price action (we called it positive)
before filing · preread $17.50 ▲ 0.78% | at our read · unknown $17.36 | +10 min · unknown $17.24 ▼ 0.72% | +30 min · unknown $17.21 ▼ 0.86% | +1 hr pending | +4 hrs pending |
The stock had already moved -0.77% between hitting EDGAR and our read finishing — deltas above are measured from our read.
Quotes via Yahoo Finance at capture time; for filings arriving outside market hours the clock starts at the next open. Not investment advice. How accurate are our calls? →
See more from October 8, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.